Trial NCT01730157

View at ClinicalTrials.gov 
Org. Study IDs: CASE1612
Secondary IDs: NCI-2012-02203

Last trial update was posted on 2016-03-10

MeSH Interventions

Antibodies Antibodies, Monoclonal Antineoplastic Agents, Immunological Immunoglobulins Ipilimumab

MeSH Conditions

Melanoma Neoplasm Metastasis Uveal Neoplasms

Other Conditions

Ciliary Body and Choroid Melanoma, Medium/Large Size Ciliary Body and Choroid Melanoma, Small Size Extraocular Extension Melanoma Iris Melanoma Liver Metastases Metastatic Intraocular Melanoma Recurrent Intraocular Melanoma Stage IV Intraocular Melanoma

Stopping Reasons

Research Cancelled

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID